SIRT7 and breast carcinoma: SIRT7 is also a prognostic factor indicating a poor outcome in colorectal cancer because it induces the EMT and cell invasion.273 However, SIRT7 inhibits breast cancer metastasis by promoting SMAD4 degradation and antagonizing TGF-β signaling.274